AT THE iQ GROUP GLOBAL,
That’s all we think about
We are a consortium of companies who work together to find, fund and develop bioscience discoveries into life-changing medical innovations – and take them to the people who need them most.
At The iQ Group Global, we are committed to transforming current cancer treatments, with our oncology drug platform TEX Core, by directly targeting tumours whilst minimizing the toxic side-effects of traditional platinum-based chemotherapy.
From the TEX Core platform, our ovarian cancer-fighting drug OxaliTEX has the proven ability to kill cancer cells, even in platinum resistant tumours with preclinical data showing the drug to be more effective than traditional chemotherapy treatments.
We are on a mission to recreate the way we fight cancer to build a new hope for ovarian cancer patients globally.
The Holy Grail World-First Needle-Free Diabetes Test
The Saliva Glucose Biosensor is the world’s first non-invasive, saliva-based glucose test for diabetes management that measure glucose in saliva, not blood. Our innovative technology will free people living with diabetes from having to use painful and invasive blood monitoring devices to manage their condition, giving them a better quality of life.
FIND OUT MORE
"*" indicates required fields